Sometimes cell cultures are not sufficient for toxicology investigations

In animal experiments, the principle of the "3Rs" applies: Replace, Reduce and Refine

According to the Swiss Animal Protection Act (Tierschutzgesetz, Article 12), an animal experiment is "... any measure involving the use of live animals designed to test a scientific assumption, obtain information, isolate or test a substance or ascertain the effect of a specific measure on the animal, as well as the use of animals for experimental behavioural research...". Great efforts are currently being made to reduce the number of laboratory animals used in experiments as far as possible, not just on ethical grounds, but also for scientific reasons. In this connection, industry and research are focusing on the strategy of the "3Rs", with the keywords Replace (replace animal experiments as far as possible by pain-insensitive systems or compensate by using methods that do not involve laboratory animals), Reduce (develop methods so that fewer laboratory animals need to be used) and Refine (improve methods so that animals undergo less discomfort during the experiments).

1. Animal experiments from antiquity to the present day

Even hundreds or thousands of years ago in Ancient Egypt and China, some healers were concerned not just with illness and health in humans, but also in animals. Even in those days, experiments were systematically carried out in order to help them gain a better understanding of the biological and medical background involved. The Greek physician Galen, born in Pergamon and recognised as the founder of physiology, acquired much of his knowledge in the 2nd century BC from experiments with monkeys and pigs. Although he located the relevant areas as being in the ventricles of the brain, he ascertained, for example, that the brain was the centre of voluntary movement and sensation. Animals were also used for investigating physiological relationships. When Jan de Wales, around 1640, alternately applied pressure to the large artery or vein in the thigh of a prepared dog carcass, he observed how the vein emptied, whereas the artery became swollen. He thus managed to obtain experimental proof of the link between the vascular system of arteries and veins. Various vaccines for humans were also developed with the aid of animal experiments, for example the vaccine against diphtheria using guinea-pigs and those against yellow fever and polio using mice and monkeys.

For some years now, transgenic animals have been used in all areas of biomedical research. As "customised" models of human illnesses, they supplement the traditional research methods wherever an illness can be associated with one or more genes. They help us obtain a better understanding of the relevant illnesses, develop new treatments and test their efficacy.

Research has to resort to animal experiments in many cases. In accordance with animal protection legislation, the researcher must try to use as few laboratory animals as possible and subject them to the least possible suffering and pain. This is not just an ethical requirement, but arises from the directions of the legislator. It also accords with industry's commercial objective: since animal experiments are time-consuming and expensive, substitute methods can frequently lead to cost savings.

2. A living organism is more than the sum of its individual cells

Tests on simple systems such as cultures of bacteria, cells or isolated tissue samples, can provide valuable information on many questions in toxicology. They are particularly suitable in comparative investigations for filtering out (screening) similar substances with similar sites of action, and can provide specific insights that often remain undiscovered due to the complexity of the metabolic reactions in a complete organism. Nowadays, cell cultures are used primarily in the areas of blood disorders or reproduction toxicology. In order to be able to test the action of antithrombotic substances in a blood vessel, for example, scientists used to have to artificially create a plug (thrombotic occlusion) in the animal. This would involve damage to the ear vein of a rabbit. But these days such anticoagulants can be analysed, and a quicker result obtained, in a test tube using donated human blood as the starting material. Similarly, phototoxic substances are no longer applied to shaven areas of rabbit skin and exposed to light, as used to happen in years past. Rather, they are detected in connective tissue cells taken from mice and placed in culture. Test substances in various concentrations are applied to the cells and the trial setup is irradiated with UV-A light. A reference substance is left in the dark. After about 24 hours, the samples are stained, enabling the investigator to determine how many cells have been damaged or died.

However, since cell cultures are simply accumulations of similar cells in a nutrient solution, they only show limited metabolism. Quantitative data on the toxic dose for the whole body can rarely be derived from such studies, nor is it possible to determine the target organs of the active drug, or the symptoms or the profile over time of a harmful effect.

Similarly, effects arising from the interplay of various organ systems or tissues in the whole body cannot be simulated using cell cultures, not to mention pain, narcotic effects, degeneration of certain sections in the central nervous system or other phenomena such as blood pressure, fever, swellings or intestinal movements. The same also applies to the simulation of various reaction patterns of different animal species or sex-specific reactions in the same species, either of which might be crucially important for the reliability of a toxicological risk assessment.

3. Statistics confirm the use of fewer animals

Thanks to the above-mentioned "3Rs" principle, the number of animal experiments requiring a permit have shown a steady decline in recent years in Switzerland, as in most EU countries: for the 16th time in succession according to a bulletin issued by the Swiss Federal Veterinary Office (FVO) in 1999. Whereas some two million laboratory animals were still in use in 1983, the figure had dropped to less than 500,000 in 1999. The precise figure stated in the animal experiment statistics is 445 682 animals (1.5% less than the previous year).

Animal experiments requiring a permit are conducted primarily in the areas of research, product safety, diagnostics and teaching. Over 90% of experiments are directly related to research concerned with human diseases. Around 70% of the animals were used in industry and a quarter in institutes and hospitals. The use of animals in basic research showed a slight increase. In Switzerland, no animal experiments for cosmetics or household products have been conducted since 1995. Nine out of ten laboratory animals are mice, rats, hamsters, guinea-pigs or other rodents. Genetically modified mice, 6.5% more overall compared to 1998, have also been used. In isolated cases, the experiments have involved the use of fish, amphibians, rabbits, monkeys, various domestic animal species and poultry.

About 7% of animals were subjected to serious harm in lethal trials or trials involving a disease model with severe symptoms. In most cases, these trials were designed to check the quality of vaccines or develop and test new medicines. 25% of the animals were subjected to moderate discomfort and 68% to little or no discomfort. There were 2142 valid cantonal animal experiment permits issued in Switzerland in 1999. 624 permits were newly issued, over a quarter of these with attached conditions, and 8 applications were rejected. As the monitoring authority, the FVO requested more specific information or issued criticisms in respect of 38 permits. 142,151 animals were used in animal experiments not requiring permits. In most cases, these involved the killing of animals in order to take organ or tissue samples, or feed trials in large poultry herds.

4. Animals must be kept under humane conditions

The Swiss Animal Protection Act (TSchG) and Animal Protection Ordinance (Tierschutzverordnung: TSchV) regulate the protection, husbandry, care and handling of animals. A complete shift in thinking about laboratory animal husbandry occurred in the eighties. Previously, the emphasis had been on standardising the keeping of individual animals under hygienic conditions with optimised climate control and lighting, and sterilised, standard feeds. But now the natural needs of laboratory animals are increasingly taken into account. Hard, perforated floors with no bedding to lie on are no longer deemed acceptable. In addition to the need for group-based husbandry for the higher mammals such as cats, dogs, pigs and monkeys, all laboratory animals now have to be provided with facilities for playing, climbing, hiding and resting.

If the experimental conditions require dogs to be kept separately, for example in the measurement of metabolic rates using labelled substances, the animals should at least remain in contact with members of the same species, via smell and acoustically and visually. Adaptation and training periods have also been introduced for the animals. Other regulations introduced in recent years also need to be taken into account: In the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes (Council of Europe Convention, 18 March 1986), crucial importance is attached to the training of individuals who care for laboratory animals and who conduct or arrange experiments. Good training, and thus a good knowledge of the needs and rights of animals, and their appropriate and technically correct use in experiments can make a significant contribution towards avoiding extreme discomfort.

5. All animal experiments are registered with the relevant cantonal authority

Appropriate forms issued by the Federal Veterinary Office must be completed in order to apply for permits and register animal experiments. At Roche, all the relevant documents are entered in the central Animal Registration, Management and Accounting System (or TIGER – an acronym derived from the German TierGesuchs- und Registriersystem), a system developed jointly with sister companies in the chemical/pharmaceutical industry, the Cantonal Veterinary Office and the Federal Veterinary Office. These days, the Animal Protection Officer in a company such as Roche or an institute is not just responsible for the administrative processing of applications, permits and surveys of experimental animal numbers. Working in conjunction with the investigators and the laboratory personnel, he also oversees the basic and advanced training of animal experts.

An animal experiment application must reveal whether the animals derive from a recognised animal breeder, can be transferred from an earlier trial or originate from some other source. Details concerning the investigators' university qualifications, specialist subjects and basic and advanced training are also recorded.

The trials must be described in detail, including the objective and the specific, direct question to be answered by the trial and the basic knowledge obtained compared to other experimental methods. Finally, the importance of the expected information yielded must be evaluated and the status of the research described.

The trial design, including the method, plan and procedure, preparation of the animals, including anaesthesia and pain control, must also be stated on the application form. Explanations concerning the methodology and interventions, operations, substance administration and sampling in the animals in each trial, the duration of the trial and the nature of the evaluation all play an important role. Reaction tests, the recording of pathophysiological parameters and statistical analyses are also described.

Details must also be provided about the expected effects on the animals' well-being (feed consumption, growth), severity of side effects, husbandry and recovery, weighed against the pain, suffering and anxiety experienced by the animals. The reasoning must be stated for the stopping criteria, method of killing, special features and advantages of the trial method and the selection of the scheduled animal species and number of animals.

If it is possible to take account of existing findings for chemicals with a similar structure, the necessary animal experiments can often be adapted to answer specific questions as a result of such structure-effect correlations. In many cases, the substance quantities to be administered can then be determined in advance, thus dispensing with the need for preliminary animal trials for dose selection.


Frog as donor of oocytes

Frogs (Xenopus laevis) serve as donor of oocytes for different in vitro- experiments

Source: Daniela Jenni, PRBM-A, Roche